Concepedia

Author

Suresh Chava

University of Alabama at BirminghamORCID

Also Known As

Chava Suresh, Suresh Chava

24

Publications

320

Citations

11

H-Index

37

Concepts

All Affiliations

University of Alabama at BirminghamYale UniversityVanderbilt University Medical CenterUniversity of Hyderabad
SC

About

Suresh Chava is an author at University of Alabama at Birmingham specializing in cell biology, medicine, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

103

2

Cell Biology

5

5

103

3

Health Sciences

2

2

36

4

Engineering

1

1

30

5

Cellular Physiology

1

1

24

Suresh Chava

×

12

Publications

295

Citations

11

H-Index

YearCitations

A novel phosphorylation by AMP-activated kinase regulates RUNX2 from ubiquitination in osteogenesis over adipogenesis

Suresh Chava, S. Chennakesavulu, B. Meher Gayatri,

Cell Death and Disease

2018

64

LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1

Parmanand Malvi, Radoslav Janoštiak, Suresh Chava,

Oncogenesis

2020

40

The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis

Lawrence David Mason, Suresh Chava, Kiran Kumar Reddi,

Cancers

2021

30

Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R

Suresh Bugide, Keshab R. Parajuli, Suresh Chava,

Oncogenesis

2020

27

Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis

Suresh Chava, Suresh Bugide, Yvonne J. K. Edwards,

Oncogenesis

2021

26

High glutamine suppresses osteogenesis through mTORC1-mediated inhibition of the mTORC2/AKT-473/RUNX2 axis

Meher B. Gayatri, Navya Naidu Gajula, Suresh Chava,

Cell Death Discovery

2022

24

Identification of the Mutational Landscape of Gynecological Malignancies

Suresh Chava, Romi Gupta

Journal of Cancer

2020

19

HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B

Parmanand Malvi, Suresh Chava, Guoping Cai,

Cell Reports Medicine

2023

18

ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE

Praveen Guruvaiah, Suresh Chava, Chiao‐Wang Sun,

Cell Death and Disease

2023

14

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Suresh Chava, Suresh Bugide, Romi Gupta,

Journal of Visualized Experiments

2020

12

Page 1